Quick Answer
MIRA PHARMACEUTICALS, INC. reported Stockholders Equity of $10.39 million for the year ending 2025.
- MIRA PHARMACEUTICALS, INC. showed an increase of +372.4% in Stockholders Equity from 2024 to 2025.
- This data is from MIRA PHARMACEUTICALS, INC.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
- XBRL data for this metric is available from 2022 to 2025 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2023: $1.20 million | Q3 2023: $8.12 million | Q1 2024: $3.16 million | Q2 2024: $2.22 million | Q3 2024: $3.57 million | Q1 2025: $1.29 million | Q2 2025: $569.9 thousand | Q3 2025: $7.55 million.
- Over the full 4 years of available data (2022 to 2025), MIRA PHARMACEUTICALS, INC.'s Stockholders Equity has grown by 1,842.9%.
- Historical annual values: Fiscal year 2025: $10.39 million | Fiscal year 2024: $2.20 million | Fiscal year 2023: $4.37 million | Fiscal year 2022: -$596.2 thousand.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: